Xvivo Perfusion AB (publ) Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Green day on Friday for Xvivo Perfusion AB (publ) stock after gaining 2.02%
(Updated on May 03, 2024)
The Xvivo Perfusion AB (publ) stock price gained 2.02% on the last trading day (Friday, 3rd May 2024), rising from kr370.50 to kr378.00. During the last trading day the stock fluctuated 2.15% from a day low at kr372.00 to a day high of kr380.00. The price has risen in 6 of the last 10 days and is up by 17.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 20 thousand more shares were traded than the day before. In total, 84 thousand shares were bought and sold for approximately kr31.73 million.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at kr381.92 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 30.45% during the next 3 months and, with a 90% probability hold a price between kr385.09 and kr498.23 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XVIVO.ST Signals & Forecast
The Xvivo Perfusion AB (publ) stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at kr371.79 and kr307.16. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 30, 2024, and so far it has fallen -0.264%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Xvivo Perfusion AB (publ) stock
Xvivo Perfusion AB (publ) finds support from accumulated volume at kr368.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved kr8.00 between high and low, or 2.15%. For the last week, the stock has had daily average volatility of 3.93%.
Our recommended stop-loss: kr364.03 (-3.69%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (XVIVO.ST) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Xvivo Perfusion AB (publ) to open at kr376.67, and during the day (based on 14 day Average True Range), to move between kr362.42 and kr393.58, which gives a possible trading interval of +/-kr15.58 (+/-4.12%) up or down from last closing price. If Xvivo Perfusion AB (publ) takes out the full calculated possible swing range there will be an estimated 8.24% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at kr379.00 (0.26%) than the support at kr368.50 (2.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Xvivo Perfusion AB (publ) stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Xvivo Perfusion AB (publ) stock to perform well in the short-term.
Current score: 4.352 Buy Candidate Unchanged
Predicted Opening Price for Xvivo Perfusion AB (publ) of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| kr376.67 ( 0.353%) | kr378.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XVIVO.ST
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 384.67 | 1.76 % | |
| R2 | 381.61 | 0.96 % | ||
| R1 | 379.72 | 0.456 % | ||
| Current price: | 378.00 | |||
| Support | S1 | 373.61 | -1.16 % | |
| S2 | 371.72 | -1.66 % | ||
| S3 | 368.67 | -2.47 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0 | . | |
| R2 | 0 | . | ||
| R1 | 379.00 | 0.265 % | ||
| Current price | 378.00 | |||
| Support | S1 | 368.50 | -2.51% | |
| S2 | 356.50 | -5.69% | ||
| S3 | 319.00 | -15.61% |
FAQ
Click here for our free guide on how to buy Xvivo Perfusion AB (publ) Stock.
